Cargando…
Antifungal agents commonly used in the superficial and mucosal candidiasis treatment: mode of action and resistance development
Recent progress in medical sciences and therapy resulted in an increased number of immunocompromised individuals. Candida albicans is the leading opportunistic fungal pathogen causing infections in humans, ranging from superficial mucosal lesions to disseminated or bloodstream candidiasis. Superfici...
Autores principales: | Bondaryk, Małgorzata, Kurzątkowski, Wiesław, Staniszewska, Monika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858657/ https://www.ncbi.nlm.nih.gov/pubmed/24353489 http://dx.doi.org/10.5114/pdia.2013.38358 |
Ejemplares similares
-
Natural Antimicrobial Peptides as Inspiration for Design of a New Generation Antifungal Compounds
por: Bondaryk, Małgorzata, et al.
Publicado: (2017) -
The Antifungal Action Mode of N-Phenacyldibromobenzimidazoles
por: Staniszewska, Monika, et al.
Publicado: (2021) -
Role of Virulence Determinants in Candida albicans’ Resistance to Novel 2-bromo-2-chloro-2-(4-chlorophenylsulfonyl)-1-phenylethanone
por: Staniszewska, Monika, et al.
Publicado: (2017) -
Candida albicans morphologies revealed by scanning electron microscopy analysis
por: Staniszewska, M., et al.
Publicado: (2013) -
Antifungal Effect of Novel 2-Bromo-2-Chloro-2-(4-Chlorophenylsulfonyl)-1-Phenylethanone against Candida Strains
por: Staniszewska, Monika, et al.
Publicado: (2016)